The SBA will be a state-of-the-art biomedical research complex complementing the University of Sydney and the Royal Prince Alfred Hospital campuses, offering a unique global concentration of biomedical research talent. The Centenary Institute will be the SBA’s primary medical research partner in what will be an exciting and internationally significant precinct.
“The almost 300 staff at the Centenary Institute have been working hard to support the case for this investment by the NSW Government, an investment that will simultaneously accelerate not only finding cures for diseases, but also the commercialisation of our discoveries, the expansion of job opportunities in this thriving sector and promotion of a healthy future for us all,” said Professor Vadas.
“Sydney will now have increased international recognition as a smart and innovative city, a new drawcard for talent, investment and economic activity,” said Mr Carrozzi.
“Having a new hub for medical research and translation in the CBD will allow Sydney to join the great innovative cities which are transforming from business headquarters into active centres for technology, science and discovery, with new and high value jobs in the heart of the city,” added Carrozzi.
Today’s announcement is a continuation of the NSW Government’s commitment to transforming the economy with new high value jobs in science, technology and medical research. The SBA will be a keystone of the recently established Tech Central precinct that will deliver a vibrant innovation and technology community in the heart of Sydney.
“We can’t build a modern, resilient city without core precincts for innovation and high value jobs. The war for talent relies on a compelling story to attract youth, families and entrepreneurs. Our compelling story in Sydney has been led by its unmatched natural beauty, its culture and business centres. Now we will add a new chapter which focuses on discovery, science and smart jobs. Tech Central and the SBA will define Sydney and the entire state as a modern and dynamic place to live, work and play,” Carrozzi said.
“Successful innovation hubs require collaboration between major anchor institutions. In the SBA, we have the Royal Prince Alfred Hospital, an iconic centre for clinical care and research which celebrates 140 years in Sydney, along with the University of Sydney, the oldest university in Australia, and the Centenary Institute, a leading medical research institute which is clinically integrated with RPA and has longstanding and strong research ties with its neighbouring universities,” added Carrozzi.
Acknowledging the role of the Hon. Stuart Ayres, New South Wales Minister for Enterprise, Investment and Trade, in the drive for exciting new technology and science jobs of the future, Carrozzi concluded, “Initiatives such as the SBA will attract the very best talent from around the world, accelerate high-value job growth and development, and enable innovative discoveries that will change not only how we live our lives, but will improve immeasurably, how those lives are actually lived.”
Professor Vadas noted that the SBA will super charge science and research at a time when the world has come to see firsthand the lifesaving work of medical researchers. “The SBA provides clear inter-connection between places for eminent research, partners that enable translation, commercialisation and job-creation and tertiary referrable hospitals and tertiary education centres in healthcare and medicine.”
The commitment to the SBA will now also encourage private sector biomedical businesses to join the precinct to help further accelerate the discovery and translation process.